Results 1 to 10 of about 754,924 (328)

Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China

open access: yesNature Communications, 2023
The current epidemic status of diabetic retinopathy in China is unclear. A national prevalence survey of diabetic complications was conducted. 50,564 participants with gradable non-mydriatic fundus photographs were enrolled.
Xuhong Hou   +19 more
doaj   +2 more sources

Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy

open access: yesNeural Regeneration Research, 2023
Diabetic retinopathy, characterized as a microangiopathy and neurodegenerative disease, is the leading cause of visual impairment in diabetic patients.
Lei Tang, Guo-Tong Xu, Jing-Fa Zhang
doaj   +2 more sources

The role of gut microbiota dysbiosis in the inflammatory pathogenesis of diabetic retinopathy [PDF]

open access: yesFrontiers in Immunology
Diabetic retinopathy, a prevalent microvascular complication of diabetes mellitus, is characterized by its increasing global prevalence and stands as the leading cause of visual impairment and blindness in adults. The pathogenesis of diabetic retinopathy
Liqing Xie, Wenjian Lin
doaj   +2 more sources

Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders [PDF]

open access: bronzeNew England Journal of Medicine, 1994
BACKGROUND Retinal ischemia induces intraocular neovascularization, which often leads to glaucoma, vitreous hemorrhage, and retinal detachment, presumably by stimulating the release of angiogenic molecules. Vascular endothelial growth factor (VEGF) is an
Lloyd Paul Aiello   +13 more
openalex   +2 more sources

DIFFERENCES OF APOLIPOPROTEIN A1 AND APOLIPOPROTEIN B LEVELS IN TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS WITH DIABETIC RETINOPATHY AND WITHOUT DIABETIC RETINOPATHY

open access: yesIJRETINA (International Journal of Retina), 2021
Introduction Apolipoprotein A1 are antiatherogenic in blood serum and have an anti-inflammatory while Apolipoprotein B describes a protein structure that is potentially atherogenic..
shabrina hanifah   +4 more
doaj   +1 more source

Diabetic retinopathy: Looking forward to 2030

open access: yesFrontiers in Endocrinology, 2023
Diabetic retinopathy (DR) is the major ocular complication of diabetes mellitus, and is a problem with significant global health impact. Major advances in diagnostics, technology and treatment have already revolutionized how we manage DR in the early ...
Tien-En Tan, T. Y. Wong
semanticscholar   +1 more source

Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation

open access: yesThe EPMA Journal, 2023
Proliferative diabetic retinopathy (PDR) the sequel of diabetic retinopathy (DR), a frequent complication of diabetes mellitus (DM), is the leading cause of blindness in the working-age population.
Martina Kropp   +12 more
semanticscholar   +1 more source

Prevalence of Diabetic Retinopathy in the US in 2021.

open access: yesJAMA ophthalmology, 2023
Importance Diabetic retinopathy (DR) is a common microvascular complication of diabetes and a leading cause of blindness among working-age adults in the US.
E. Lundeen   +6 more
semanticscholar   +1 more source

Characteristics Associated with Early Worsening of Retinopathy in Patients with Type 2 Diabetes Diagnosed with Retinopathy at Their First Visit: A Retrospective Observational Study

open access: yesJournal of Diabetes Research, 2021
Aims/Introduction. To investigate whether the occurrence of early worsening of diabetic retinopathy in patients with type 2 diabetes diagnosed with simple or preproliferative diabetic retinopathy at their first visit differed according to HbA1c reduction
Sayaka Wakabayashi Sugawa   +6 more
doaj   +1 more source

A deep learning system for detecting diabetic retinopathy across the disease spectrum

open access: yesNature Communications, 2021
Retinal screening contributes to early detection of diabetic retinopathy and timely treatment. To facilitate the screening process, we develop a deep learning system, named DeepDR, that can detect early-to-late stages of diabetic retinopathy.
Ling Dai   +19 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy